No Data
No Data
Analysts' Opinions Are Mixed on These Healthcare Stocks: Elevance Health (ELV), CVS Health (CVS) and Abbott Laboratories (ABT)
Abbott Labs Makes Marketing Push For New Glucose Monitors, Targets Health-Conscious Consumers
Abbott Laboratories (NYSE:ABT) CEO Robert Ford said the company will use a mix of TV advertisements and guerilla marketing to promote the U.S. launch of Lingo, its glucose monitoring device.This
Morgan Stanley Maintains Abbott Laboratories(ABT.US) With Hold Rating, Maintains Target Price $107
Morgan Stanley analyst Patrick Wood maintains $Abbott Laboratories(ABT.US)$ with a hold rating, and maintains the target price at $107.According to TipRanks data, the analyst has a success rate of 50.
Morgan Stanley Keeps Their Hold Rating on Abbott Laboratories (ABT)
What Are the Most Profitable Stocks of All Time? The Answer Might Surprise You.
An academic with a large following on Wall Street recently published a paper showing the stocks that have seen the strongest returns over time
Nephron Adjusts Price Target on Abbott Laboratories to $110 From $115
Abbott Laboratories (ABT) has an average outperform rating and a price target range of $104 to $143, according to analysts polled by Capital IQ.Price: 100.45, Change: +0.38, Percent Change: +0.38